Fecal Impaction Management

Life-Threatening Complications

Colonic perforation and stercoral ulceration can occur from pressure necrosis of the bowel wall, leading to peritonitis and sepsis, as reported by the Annals of Oncology 1, 2
Rectal bleeding and stercoral ulcers develop from chronic pressure and ischemia, according to the Annals of Oncology 1, 2
Urinary tract obstruction from mass effect on the bladder and ureters can occur, as noted by the Annals of Oncology 1, 2
Renal insufficiency secondary to urinary obstruction and dehydration is a potential complication, as reported by the Annals of Oncology 1, 2
Severe dehydration and electrolyte imbalances, including hypermagnesemia, can occur if magnesium-containing laxatives are used, according to the Annals of Oncology 1, 2

Fecal incontinence from paradoxical overflow diarrhea, where watery stool leaks around the impaction, can occur, as noted by the Annals of Oncology and Praxis Medical Insights 1, 2, 3
Decubitus ulcers in immobilized patients can develop, according to the Annals of Oncology 1, 2

The first-line treatment for distal fecal impaction is digital fragmentation and extraction after appropriate analgesia/anxiolytic administration, as recommended by Praxis Medical Insights 3, 4
Administer pain medication and anxiolytic before the procedure, as suggested by Praxis Medical Insights 3, 4
Position patient in left lateral decubitus position, as recommended by Praxis Medical Insights 3
Perform manual fragmentation and extraction of stool with lubricated gloved finger, as suggested by Praxis Medical Insights 3, 4
Follow with water or oil retention enema to facilitate passage, as recommended by Praxis Medical Insights 3, 4
Once distal colon is partially emptied, administer oral polyethylene glycol (PEG), as suggested by the Annals of Oncology 1, 2

Implement a maintenance bowel regimen immediately after disimpaction to prevent recurrence, as recommended by the Annals of Oncology and Praxis Medical Insights 1, 2, 4
Preferred first-line laxatives include osmotic laxatives (PEG 17g daily, lactulose, or magnesium salts) or stimulant laxatives (senna, bisacodyl), as suggested by the Annals of Oncology and Praxis Medical Insights 1, 2, 4
Goal is one non-forced bowel movement every 1-2 days, as recommended by the Journal of the National Comprehensive Cancer Network and Praxis Medical Insights 3, 5
Avoid bulk laxatives (psyllium) in patients with limited mobility or opioid-induced constipation, as suggested by the Annals of Oncology and Praxis Medical Insights 1, 2, 4

Elderly patients with degenerative changes in the enteric nervous system are at high risk, as reported by the Annals of Oncology 1, 2
Opioid users require prophylactic laxatives, as recommended by the Annals of Oncology and the Journal of the National Comprehensive Cancer Network 1, 2, 5
Immobilized or institutionalized patients with limited toilet access are at high risk, as noted by Praxis Medical Insights 3, 4
Cancer patients receiving chemotherapy or radiotherapy are at high risk, as reported by the Annals of Oncology and Gut 1, 2, 6